Delphi consensus recommendations for neuraxial anaesthesia in adults with platelet disorders and coagulation defects: Communication from the ISTH SSC Subcommittee on von Willebrand factor.
Wynn Peterson, Rachel Martin, Donald Arnold, Brendan Carvalho, Adam Cuker, Jeff Gadsden, Drew Provan, Natalia Rydz, Eliane Shore, David Kuter, Peter Kouides, Michelle Lavin, Paula James, Dale Engen, Michelle Sholzberg
{"title":"Delphi consensus recommendations for neuraxial anaesthesia in adults with platelet disorders and coagulation defects: Communication from the ISTH SSC Subcommittee on von Willebrand factor.","authors":"Wynn Peterson, Rachel Martin, Donald Arnold, Brendan Carvalho, Adam Cuker, Jeff Gadsden, Drew Provan, Natalia Rydz, Eliane Shore, David Kuter, Peter Kouides, Michelle Lavin, Paula James, Dale Engen, Michelle Sholzberg","doi":"10.1016/j.jtha.2025.01.019","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Neuraxial anaesthesia is used for pain management in surgical and non-surgical settings. Spinal/epidural haematomas likely occur in between 1:10,000 and 1:200,000 procedures. Risk is thought to be greater in patients with bleeding disorders/thrombocytopenia and there are no existing comprehensive recommendations to guide neuraxial anaesthesia in these patients.</p><p><strong>Objectives: </strong>The study's objective was to develop recommendations to advise clinicians on treatment thresholds for neuraxial anaesthesia in patients with platelet disorders/coagulation defects.</p><p><strong>Methods: </strong>A four-round electronic modified Delphi consensus study was conducted. A steering committee generated the original Delphi statements and refined them based on panelist feedback. Consensus was achieved if ≥70% of participants agreed/strongly agreed or disagreed/strongly disagreed with a statement. This project was endorsed by the International Society on Thrombosis and Hemostasis Scientific and Standardization Committee Subcommittee on von Willebrand factor.</p><p><strong>Results: </strong>Forty-five experts participated (42% response rate) with an essentially equal number of haematologists and anaesthesiologists. Thirty consensus statements were developed for 11 disorders ranging from various causes of thrombocytopenia, inherited platelet function disorders (IPFD), and single or multiple coagulation defects in obstetrical and non-obstetrical patients. Risk of sampling bias is present due to a predominantly North American sample, attrition (common in Delphi studies), and steering committee participation in the Delphi rounds.</p><p><strong>Conclusions: </strong>This is the first set of consensus recommendations for neuraxial anaesthesia in adult patients with an array of platelet disorders/coagulation defects. These recommendations, based on the best available evidence and expert opinion, provide a decision framework for clinicians when faced with this challenging scenario.</p>","PeriodicalId":17326,"journal":{"name":"Journal of Thrombosis and Haemostasis","volume":" ","pages":""},"PeriodicalIF":5.5000,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thrombosis and Haemostasis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jtha.2025.01.019","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Neuraxial anaesthesia is used for pain management in surgical and non-surgical settings. Spinal/epidural haematomas likely occur in between 1:10,000 and 1:200,000 procedures. Risk is thought to be greater in patients with bleeding disorders/thrombocytopenia and there are no existing comprehensive recommendations to guide neuraxial anaesthesia in these patients.
Objectives: The study's objective was to develop recommendations to advise clinicians on treatment thresholds for neuraxial anaesthesia in patients with platelet disorders/coagulation defects.
Methods: A four-round electronic modified Delphi consensus study was conducted. A steering committee generated the original Delphi statements and refined them based on panelist feedback. Consensus was achieved if ≥70% of participants agreed/strongly agreed or disagreed/strongly disagreed with a statement. This project was endorsed by the International Society on Thrombosis and Hemostasis Scientific and Standardization Committee Subcommittee on von Willebrand factor.
Results: Forty-five experts participated (42% response rate) with an essentially equal number of haematologists and anaesthesiologists. Thirty consensus statements were developed for 11 disorders ranging from various causes of thrombocytopenia, inherited platelet function disorders (IPFD), and single or multiple coagulation defects in obstetrical and non-obstetrical patients. Risk of sampling bias is present due to a predominantly North American sample, attrition (common in Delphi studies), and steering committee participation in the Delphi rounds.
Conclusions: This is the first set of consensus recommendations for neuraxial anaesthesia in adult patients with an array of platelet disorders/coagulation defects. These recommendations, based on the best available evidence and expert opinion, provide a decision framework for clinicians when faced with this challenging scenario.
期刊介绍:
The Journal of Thrombosis and Haemostasis (JTH) serves as the official journal of the International Society on Thrombosis and Haemostasis. It is dedicated to advancing science related to thrombosis, bleeding disorders, and vascular biology through the dissemination and exchange of information and ideas within the global research community.
Types of Publications:
The journal publishes a variety of content, including:
Original research reports
State-of-the-art reviews
Brief reports
Case reports
Invited commentaries on publications in the Journal
Forum articles
Correspondence
Announcements
Scope of Contributions:
Editors invite contributions from both fundamental and clinical domains. These include:
Basic manuscripts on blood coagulation and fibrinolysis
Studies on proteins and reactions related to thrombosis and haemostasis
Research on blood platelets and their interactions with other biological systems, such as the vessel wall, blood cells, and invading organisms
Clinical manuscripts covering various topics including venous thrombosis, arterial disease, hemophilia, bleeding disorders, and platelet diseases
Clinical manuscripts may encompass etiology, diagnostics, prognosis, prevention, and treatment strategies.